CBR3 and childhood malignant neoplasm: Our prior work with the Children’s Oncology Group identified a single nucleotide polymorphic variant in the CBR3 gene (rs1056892, CBR3 V244M) associated with the risk of anthracycline-related cardiomyopathy in survivors of childhood cancers [3].